Suppr超能文献

丝裂原活化蛋白激酶磷酸酶-1 的缺失通过抑制细胞死亡诱导的 DNA 片段化因子 A(DFFA)样效应物 C(CIDEC)/脂肪特异性蛋白 27 来保护肝脏免于脂肪变性。

Loss of mitogen-activated protein kinase phosphatase-1 protects from hepatic steatosis by repression of cell death-inducing DNA fragmentation factor A (DFFA)-like effector C (CIDEC)/fat-specific protein 27.

机构信息

Department of Pharmacology and Program in Integrative Cell Signaling and Neurobiology of Metabolism, Yale University School of Medicine, New Haven, Connecticut 06520, USA.

出版信息

J Biol Chem. 2011 Jun 24;286(25):22195-202. doi: 10.1074/jbc.M110.210237. Epub 2011 Apr 26.

Abstract

The integration of metabolic signals required for the regulation of hepatic lipid homeostasis is complex. Previously, we showed that mice lacking expression of the mitogen-activated protein kinase (MAPK) phosphatase-1 (MKP-1) have increased fatty acid oxidation and are protected from the development of hepatic steatosis. Here, we show that leptin receptor-deficient (db/db) mice lacking MKP-1 are also resistant to the development of hepatic steatosis. Microarray analyses of livers from db/db mice lacking MKP-1 showed suppression of peroxisome proliferator-activated receptor γ (PPARγ) target genes. We identified the fat-specific protein 27 (Fsp27), which promotes PPARγ-mediated hepatic steatosis, as repressed in livers of both db/db and high fat diet-fed mice lacking MKP-1. Hepatocytes from MKP-1-deficient mice exhibited reduced PPARγ-induced lipid droplet formation. Mechanistically, loss of MKP-1 inhibited PPARγ function by increasing MAPK-dependent phosphorylation on PPARγ at its inhibitory residue of serine 112. These results demonstrate that in addition to inhibiting hepatic fatty acid oxidation, MKP-1 promotes hepatic lipogenic gene expression through PPARγ. Hence, MKP-1 plays an important role in MAPK-mediated control of hepatic lipid homeostasis.

摘要

代谢信号的整合是调节肝脏脂质稳态的复杂过程。此前,我们发现缺乏丝裂原活化蛋白激酶(MAPK)磷酸酶-1(MKP-1)表达的小鼠,其脂肪酸氧化增加,并能防止肝脂肪变性的发生。在这里,我们发现缺乏 MKP-1 的瘦素受体缺陷(db/db)小鼠也能抵抗肝脂肪变性的发生。MKP-1 缺乏的 db/db 小鼠肝脏的微阵列分析显示过氧化物酶体增殖物激活受体 γ(PPARγ)靶基因受到抑制。我们鉴定出脂肪特异性蛋白 27(Fsp27),它促进了 PPARγ 介导的肝脂肪变性,在缺乏 MKP-1 的 db/db 和高脂肪饮食喂养的小鼠的肝脏中受到抑制。MKP-1 缺乏的肝细胞表现出 PPARγ 诱导的脂滴形成减少。从机制上讲,MKP-1 通过增加 PPARγ 在其抑制性丝氨酸 112 残基上的 MAPK 依赖性磷酸化来抑制 PPARγ 功能。这些结果表明,除了抑制肝脏脂肪酸氧化外,MKP-1 还通过 PPARγ 促进肝脏脂肪生成基因的表达。因此,MKP-1 在 MAPK 介导的肝脏脂质稳态控制中发挥重要作用。

相似文献

引用本文的文献

本文引用的文献

5
Prevention of steatosis by hepatic JNK1.通过肝 JNK1 预防脂肪变性。
Cell Metab. 2009 Dec;10(6):491-8. doi: 10.1016/j.cmet.2009.09.007.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验